Harmonising Bioequivalence: Advancing Global Access to Generic Medicines

26 February 2025

PharmaBoardroom’s interview with President Stephan Eder

18 February 2025

President of Medicines for Europe, Stephan Eder, highlights the association’s […]

Biosimilar medicines: the intersection of access, affordability, and innovation

3 February 2025

Director of Biosimilar Policy & Science at Medicines for Europe, […]

Building A Sustainable Market: new Medicines for Europe President sets out priorities

20 January 2025

Newly appointed Medicines for Europe President Stephan Eder discusses the […]

STADA’s Stephan Eder sets Access, Manufacturing and Sustainability at heart of Medicines for Europe Presidency

13 January 2025

Industry Proposes Phased Rollout of ePI for Patient Safety and Environmental Sustainability

8 January 2025

Maximising the impact of Biosimilar Medicines requires strategic action in Europe

5 December 2024

Medicines for Europe Statement on Unitary SPC Legislative Process

19 November 2024

Joint Industry Statement on EU-Mercosur Negotiations

18 November 2024

Council adoption of Urban Waste Water Treatment Directive will generate a tsunami of essential and critical medicine shortages across Europe

5 November 2024